Work

Weekly EZN-2208 (PEGylated SN-38) in combination with bevacizumab in patients with refractory solid tumors

Year: 2013

Type: article

Study design: Clinical Trial

Source: Investigational New Drugs

DOI: 10.1007/s10637-013-0048-3

Authors: Woondong Jeong, Sook Ryun Park, Annamaria Rapisarda, Nicole Fer, Robert J. Kinders, Alice Chen, Giovanni Melillo, Baris Turkbey, Seth M. Steinberg, Peter Choyke, James H. Doroshow, Shivaani Kummar

Institutions: National Cancer Institute, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research Inc. (United States), Center for Cancer Research

Language: English

Topic: Cancer, Hypoxia, and Metabolism

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: green

Funders: National Institutes of Health, National Cancer Institute

Awards: G386607036, G5888954722, G9000058990, G9000065556, G9000186062

OpenAlex ID: W1995012315

FWCI: 0.933

Cites: 22

Cited by: 27

Related to: 10